Namzaric (Allergan, Inc.)
Welcome to the PulseAid listing for the Namzaric drug offered from Allergan, Inc.. This NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | memantine hydrochloride and donepezil hydrochloride |
| SUBSTANCE NAME: | MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-07-18 |
| END MARKETING DATE: | 0000-00-00 |
Namzaric HUMAN PRESCRIPTION DRUG Details:
| Item Description | Namzaric from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2016-07-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0456-1207_d695cdc0-7d22-4eb1-947e-c7c4005473e7 |
| PRODUCT NDC: | 0456-1207 |
| APPLICATION NUMBER: | NDA206439 |
Other MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
